News        Sectors        Watchlists

PAVmed Inc. (PAVM)

PAVmed stock forecast: buy or sell

Close on Sep 25th, 2020
$1.79 0.01%
3 months performance
Published: September 26th, 2020 - 10:20

PAVmed stock outlook

  • PAVmed closed yesterday at $1.79 (0.56%) prior to reporting earnings at
  • Last February price started dropping and drawed 6 consecutive lower tops. shares price lost a -48.12% since the downtrend started.
  • PAVmed Inc. operates as a medical device company in the United States.

The viewpoints written in this article are personal and not recommendations for you to buy or sell shares. The author of this paper does not have any knowledge of the individual circumstances of the reader, his or her finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are provided for informational reasons only

PAVmed stock charts

Should I buy PAVmed stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is PAVM stock a buy?

In the current situation of PAVmed there is not any eligible buy setup. This doesn't mean we expect a selloff for PAVM in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell PAVmed stock?

Do you know when is it time to sell PAVmed?. Trading strategies allow us to avoid impetuous decisions based on our feelings or the noise surrounding the market. When selling, as well as buying, our setups are very easy to use but are only applicable for selling stocks you already own, not for selling short PAVM stock

A golden rule is that you should not keep a trade that shows a greater losses than those expected at the time of the buy. When to sell your stock always has to be ruled by the stop-loss (automatic or manual)

Is it time to sell PAVmed stock?

In the current situation of PAVmed there is not any eligible sell setup, so PAVmed stock holders with operations in green can keep their positions

Analysts' recommendations to buy or sell PAVmed stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

We don't have any rating posted in the previous 30 days for PAVmed

Technical analysis

From a technical standpoint, PAVmed continues trending lower since last February, and has accumulated a selloff of -48.12%. Like in all downtrends, the stock oscillates drawing lower tops and bottoms. In this case, we have seen 7 consecutive lower tops

SMAs overview

A favorite tool of many trading systems are the moving averages, that easily show market momentum. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages

PAVM SMAs chart

Supports and resistances

Technical analysts use supports and resistances to spot price points in the stock price action that tend to act as barriers, containing the price of an asset to move in certain direction. A support level is a level where the price tends to stop as it falls. This means that the price is more likely to "bounce off" this level rather than break through it. However, if the price breaks down this level, it will probably continue declining until approaching another support level. On the contrary, a resistance level is where the price tends to find resistance as it moves up. In the same way, the price is more likely to "bounce off" at this level, and if it finally breaches this level, the price will climb more easily until it hits the next resistance

The current resistances are:

  • R1: $1.90 (6.15% above)
  • R2: $1.91 (6.7% above)
  • R3: $1.97 (10.06% above)
  • The current supports are:

  • S1: $1.71 (-4.47% below)
  • S2: $1.69 (-5.59% below)
  • S3: $1.40 (-21.79% below)
  • Bollinger bands

    This is an indicator that was designed in the 1980s by John Bollinger. It is composed of three bands that are outlined superimposed on the price evolution chart:

    • The central band is a moving average, usually a simple moving average calculated with 20 periods
    • The upper band is calculated by adding to the value of the simple moving average 2 times the standard deviation of the moving average
    • The lower band is calculated by subtracting from the simple moving average 2 times the standard deviation of the moving average

    The price is trading very close to the lower Bollinger band, signaling some level of oversold in recent sessions. This is not a buy point, as price can trade in these levels for many days and weeks

    PAVM RSI chart

    Relative strength index

    The relative strength index (RSI) is a technical indicator used in the analysis of financial markets. Its objective is to chart the current and past weakness or strength of a stock or market based on the closing prices of a recent trading period. Like other oscillation indicators, the RSI moves in a range between 0 and 100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in 1978

    When the Relative Strength Indicator (RSI) fluctuates for so long below 70 and above 30, without indicating moments of overbought and oversold, the indicator loses its usefulness, and we are currently in one of these situations.

    PAVM RSI chart

    Earnings and financials

    PAVmed Inc. (PAVM) released second-quarter earnings of $-0.13 per share, poorly missing the Market consensus estimate of $-0.10 per share. This quarterly report represents an earnings surprise of -30%. Estimated turnover for this quarter was $1.3 million but PAVmed strongly uplifted by 100%, reporting $0.00.

    This compares to earnings of $-0.13 per share same quarter last year, so current EPS means 0%. Looking at revenues, figures slightly moved compared to $0.00 same quarter a year ago.

    PAVmed is hosting the earnings call. If you own or you are planning to buy PAVmed shares, be careful as financial reporting day usually has a very high volatility, and price can jump up or down with exceptionally low liquidity and not honouring your buy or stop-loss orders. You can probably find more details about the earnings conference call and the financial reports on the Investor Relations section of its website:

    PAVM revenues and profits chart